Log In
BCIQ
Print this Print this
 

Sodium-glucose cotransporter 2 (SGLT2)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Sodium-glucose cotransporter 2 (SGLT2)

BCIQ
Print ChartPrint this
0 0 0 1 0 0 0 1 0 2 0 0 0 0 1 1 6 5 1 5 5
Phases of DevelopmentPreclinicalPhase IPhase IIPhase IIIRegistrationApprovedMarketed
Endocrine / Metabolic

1

1

6

5

1

5

5

Hepatic

1

0

2

0

0

0

0

Renal

0

0

0

1

0

0

0




 Products Targeting Sodium-glucose cotransporter 2 (SGLT2)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

14

$2,639.4M

$398.2M

$1,638.9M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today